Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
On-chain US stock protocol BBX officially launched: 7×24 hours perpetual trading for popular US stocks now available

On-chain US stock protocol BBX officially launched: 7×24 hours perpetual trading for popular US stocks now available

AIcoinAIcoin2026/04/06 02:57
Show original
BBX news: Yesterday, the on-chain stock tokenization and trading protocol BBX officially announced its launch. The introduction of this protocol marks a deep integration between the traditional securities market and crypto-native liquidity, accomplishing a pivotal leap from pure "asset tokenization" to "asset derivatives." Highlights: — All-weather high-leverage trading: The platform allows users to directly use USDC / USDT stablecoins for 24/7 uninterrupted perpetual contract trading of US stocks, with up to 20x leverage, completely breaking the traditional US stock trading restrictions of time zones and weekend market closures. — First batch of top-tier instruments: The initial launch supports 10 of the most liquid and highly watched global US stocks, precisely covering AI tech giants and core crypto-related assets: NVDA, TSLA, AAPL, AMZN, GOOGL, AMD, PLTR, MSTR, HOOD, CRCL. — Robust compliance and asset segregation: Underlying assets of the protocol are independently segregated and custodied by top global brokers. The tokenization process is strictly managed by licensed institutions authorized under the Swiss DLT Act, ensuring a 1:1 absolute anchor between on-chain derivatives and underlying physical stock assets. Source: bbx.com
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Immunology and inflammation biotech company Bambusa (BBTX.US) prices IPO at $15-17 per share, aims to raise $150 million.

Bambusa Therapeutics plans to raise 150 millions USD by issuing 9.4 million shares at a price range of 15 to 17 USD per share.

智通财经•2026/10/27 07:21

The Bank of Japan’s price trend indicator rises above 3%, providing grounds for further rate hikes

The Bank of Japan's indicator for measuring underlying inflation has risen to its highest level in three years, far surpassing the bank's 2% target, providing grounds for authorities to continue raising interest rates.

智通财经•2026/10/27 07:17
The Bank of Japan’s price trend indicator rises above 3%, providing grounds for further rate hikes

$95 billion bet on AI! Meta (META.US) launches rare equity financing, while Goldman Sachs still maintains "Buy" rating

Meta announced a $95 billion equity financing, with NVIDIA, AMD, and Broadcom planning to subscribe $5 billion. Goldman Sachs reiterated its "buy" rating with a target price of $885.

智通财经•2026/10/27 07:07